The aim of this analysis was to determine suPAR, GDF-15, H-FABP, and sST2 levels in CHF patients and, furthermore, to investigate their association with EF in comparison to the well-established biomarker N-terminal pro brain natriuretic peptide (NT-proBNP). Here, FABP3 is linked to congestive heart failure.